Product Reports Resources Pricing Login Book a demo

NantCell | Nantworks

Biotech & Life Sciences · Culver City, United States · Founded 2014

Developing knowledge by harnessing the power of the immune system to treat cancer

Company overview

NantCell | Nantworks company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2014
Headquarters
Culver City, United States
Employees
68
Open positions
None listed
Dealroom signal
40.7
Investment activity
13 companies · latest Feb 2026
Capital deployed
$355M
Preferred round
ACQUISITION
sub industryBioTechnologybusiness modelManufacturingindustryHealthsectorBiotechnologysectorOncologysectorDrug DevelopmentsectorMolecularsectorBiotech and PharmasectorDT and LSsectorscience-basedclient focusb2bclient focusb2ctechnologyHardware

Valuation & funding

NantCell | Nantworks funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VCOther financing Dec 2018 $30M $120M Undisclosed
GROWTH EQUITY VCOther financing Jan 2016 $57M $399M Undisclosed
GROWTH EQUITY VCOther financing Jun 2015 $75M $525M Undisclosed
EARLY VCOther financing May 2014 $15M $60M Undisclosed
Showing 4 recorded eventsUnlock the complete deal history →

Growth signals

NantCell | Nantworks website traffic

Latest recorded traffic for NantCell | Nantworks is 340 monthly website visits, down 85.8% over the last three months. NantCell | Nantworks's team grew 0% over the past year.

Latest monthly visits340 3-month web change-85.8% 1-year team growth0%
Monthly website visits105 observations · Sep 2017–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

NantCell | Nantworks compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
Foundation MedicineTransformation in cancer care, where each patient’s treatment is informed by a deep understanding of the molecular changes that contribute to their disease Boston, United States Acquired 1,762 $97M $5.3B
Immatics biotechnologiesCombines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets Tübingen, Germany Operational
ProteaProtea is a commercial stage molecular information company, leading in the field of mass spectrometey imaging. http://t.co/Jy8X3awz9r Morgantown, United States Operational
BiodesixA molecular diagnostics company at the forefront of innovation in oncology Boulder, United States Operational
NanobiotixNanobiotix is a leading, late clinical-stage nanomedicine company pioneering new approaches to significantly change patient outcomes by bringing nanophysics to the heart of the cell Paris, France Operational
Innovent BiologicsInnovent Biologics is a biopharmaceutical company developing and manufacturing monoclonal antibodies Suzhou Shi, China Operational
RedHill BiopharmaRedHill (NASDAQ: RDHL) is a specialty biopharmaceutical company focused on proprietary drugs for gastrointestinal diseases Raleigh, United States Operational
Convert PharmaceuticalsHypoxia-activated prodrugs targeting treatment-resistant tumors Liège, Belgium Operational
Showing 8 of the closest matchesCompare every metric →

Capital deployed

NantCell | Nantworks investments and acquisitions

Recent portfolio relationships for companies that also act as investors or acquirers.

SHINE TechnologiesJanesville, United StatesDeploying and scaling near-term applications of fusion technology that we hope will one day lead to powering the world $1.2Bvaluation Veradigm (Allscripts Healthcare Solutions)Chicago, United StatesAn iPad application for managing enterprise and professional electronic health records ImmunityBioCulver City, United StatesImmunityBio pioneers innovative therapies to conquer disease through immune system reprogramming $9.1Bvaluation Integrity HealthcareBoynton Beach, United StatesHelping companies find talent faster Altor BioScienceMiramar, United StatesResearches and develops immunotherapeutic agents for the treatment of cancer, viral infections and autoimmune diseases $45Mvaluation Precision BiologicsDallas, United StatesCancer immunotherapy platform with 2 unique clinical stage monoclonal antibodies $200Mvaluation VivaBioCellUdine, ItalyVivaBioCell develops products based on cell culture and tissue engineering for the diagnosis of autoimmune diseases $1.9Mvaluation KeyssaCampbell, United StatesA new category of contactless connectivity based on a tiny, solid-state system that simplifies secure, instant data flow between devices $100Mvaluation AccuradioChicago, United StatesMultichannel internet radio station that caters to audiences with varied tastes $10Mvaluation Strand DiagnosticsIndianapolis, United StatesStrand Diagnostics develops and markets the know error® system which utilizes bar coding and DNA testing to confirm surgical biopsy samples $120Mvaluation iVisitSanta Monica, United StatesA range of video conferencing, voice call, instant messaging, file sharing, and web co-browsing solutions

Talent graph

NantCell | Nantworks's talent

Book a demo to see the people
Team profiled 9 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Where NantCell | Nantworks has talent and traffic

Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

In the news

Latest news about NantCell | Nantworks

Recent press, funding announcements, and product moves mentioning NantCell | Nantworks — open to read from the original sources.

See all news

Market sentiment

What the market is saying about NantCell | Nantworks

An AI-synthesized read of the highest-engagement posts about NantCell | Nantworks on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See NantCell | Nantworks’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.